Zofran
Electroacupuncture
Jiuda ZhaoPhase 3Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 81/ 100
Competitive context
13 Active assets in the Electroacupuncture cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Netupitant Jiuda Zhao | Phase 3 | B |
DEXAMETHASONE Jiuda Zhao | Phase 3 | B |
Tropisetron Jiuda Zhao | Phase 3 | B |
Palonosetron Jiuda Zhao | Phase 3 | B |
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]- Jiuda Zhao | Phase 3 | B |
View all 14 →
Same molecule, other indications
Zofran is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →